Nektar Therapeutics Financial Market Data
| Last Close 21-Nov-2008 |
$3.74 |
Price/ Sales Ratio |
2.71 |
| 52-Week High |
$7.67 |
Price/ Book Ratio |
3.18 |
| 52-Week Low |
$2.45 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
(0.4) |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$345.7 |
Return on Assets |
(11.0%) |
| Shares Outstanding (mil.) |
92.4 |
Return on Equity |
(51.6%) |
| Dividend Rate |
-- |
Current Ratio |
8.46 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
3.10 |
| # of Institutional Holders |
129 |
% Owned by Institutions |
86.0% |
| Latest Short Interest Ratio |
14.90 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
(54.0%) |
2.3% |
23.6% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
